StratifAI

Berlin, Germany · Founded 2023 · Privately Held (backing)

Developer of a precision oncology platform designed to advance cancer diagnostics through next-generation biomarker discovery. StratifAI is based in Berlin, Germany and was founded in 2023. It has raised $16.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$16.3M
Last round
—
Valuation — not yet established

No valuation for StratifAI is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($16.3M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of StratifAI with a free account
  • ·The complete investor list: 14 names
  • ·Watch StratifAI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

StratifAI funding history

No rounds on record

No funding rounds for StratifAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How StratifAI's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For StratifAI, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about StratifAI

How much has StratifAI raised?
StratifAI has raised $16.3M in total funding across its recorded rounds.